Related Experiment Video
Updated: Jul 6, 2026

11:42
Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
Published on: September 12, 2014
[Amniotic membrane for ocular surface reconstruction after conjunctival squamous cell carcinoma resection]
Paulo Roberto de Carvalho-Rêgo1, José Alvaro Pereira Gomes, Priscila Luppi Ballalai
1Setor de Córnea e Doenças Externas, Departamento de Oftalmologia, Universidade Federal de São Paulo, São Paulo, SP, Brasil. paulo.r.carvalho@globo.com
Arquivos Brasileiros De Oftalmologia
|April 15, 2008
Summary
Human amniotic membrane transplantation offers a viable solution for reconstructing the ocular surface after conjunctival squamous cell carcinoma resection, demonstrating good stability in most patients.
Area of Science:
- Ophthalmology
- Oncology
- Regenerative Medicine
Context:
- Conjunctival squamous cell carcinoma (cSCC) is a malignancy affecting the ocular surface.
- Ocular surface reconstruction is critical after tumor resection to preserve visual function and ocular integrity.
- Human amniotic membrane (HAM) has demonstrated potential in various reconstructive ophthalmic procedures.
Purpose:
- To evaluate the efficacy of human amniotic membrane transplantation for ocular surface reconstruction following the surgical resection of conjunctival squamous cell carcinoma.
- To assess the outcomes and complications associated with HAM transplantation in this specific oncological context.
Summary:
- Eight patients with cSCC underwent tumor resection and HAM transplantation; three also had corneal epitheliectomy and limbal autograft.
- Follow-up averaged 17.8 months. Successful reconstruction with good ocular surface stability was achieved in 71.4% of patients.
- Partial success with mild scarring occurred in 28.6%; one patient experienced tumor recurrence requiring exenteration.
Impact:
- HAM transplantation presents a promising reconstructive option for ocular surface defects after cSCC resection.
- This technique may improve visual outcomes and reduce the need for more extensive surgical interventions.
- Further research can optimize HAM application protocols for cSCC management.

